Posts

Showing posts with the label mass spectrometry market

Mass Spectrometry Market: Increasing Spending on Pharmaceutical R&D

Image
  What This Report Will Provide? This study involved four major activities in estimating the current size of the mass spectrometry market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments. Expected Revenue Growth: [190 Pages Report]  The mass spectrometry market size is expected to grow from an estimated USD 4.1 billion in 2020 to USD 5.6 billion by 2025, at a CAGR of 6.5%. Major Growth Boosters: Growth in the mass spectrometry market is primarily driven by factors such as government initiatives for pollution control and environmental testing, increas

Mass Spectrometry Market: Major Revenue Surge is Expected in Pharmaceuticals Application

Image
  What This Report Will Provide? This study involved four major activities in estimating the current size of the mass spectrometry market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments. Expected Revenue Growth: The mass spectrometry market is expected to grow from USD 4.6 billion in 2019 to USD 6.3 billion by 2024, at a CAGR of 6.7%. Major Growth Boosters: Growth in the mass spectrometry market is primarily driven by factors such as government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D